BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29702023)

  • 21. Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.
    Beheshti M; Rezaee A; Geinitz H; Loidl W; Pirich C; Langsteger W
    J Nucl Med; 2016 Oct; 57(Suppl 3):55S-60S. PubMed ID: 27694173
    [No Abstract]   [Full Text] [Related]  

  • 22. Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan.
    Woodhead GJ; Avery RJ; Kuo PH
    Clin Nucl Med; 2017 Dec; 42(12):930-938. PubMed ID: 29036001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observer agreement and accuracy of 18F-sodium fluoride PET/computed tomography in the diagnosis of skull-base bone invasion and osseous metastases in newly diagnosed nasopharyngeal carcinoma.
    Xiao J; Wang D; Guo B; Wang L; Su M; Xu H
    Nucl Med Commun; 2020 Sep; 41(9):942-949. PubMed ID: 32796483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of bone-seeking novel radiotracer
    Passah A; Tripathi M; Ballal S; Yadav MP; Kumar R; Roesch F; Meckel M; Sarathi Chakraborty P; Bal C
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):41-49. PubMed ID: 27455986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method.
    Lapa P; Marques M; Costa G; Iagaru A; Pedroso de Lima J
    Nucl Med Commun; 2017 Apr; 38(4):325-332. PubMed ID: 28230714
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Langsteger W; Rezaee A; Pirich C; Beheshti M
    Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
    Guo HH; Moradi F; Iagaru A
    Nucl Med Commun; 2016 Sep; 37(9):975-82. PubMed ID: 27111100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
    Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
    Lapa P; Saraiva T; Silva R; Marques M; Costa G; Lima JP
    Acta Med Port; 2017 Jan; 30(1):53-60. PubMed ID: 28501038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of 18F-NaF PET/CT in bone metastases.
    Zhang-Yin J; Panagiotidis E
    Q J Nucl Med Mol Imaging; 2023 Dec; 67(4):249-258. PubMed ID: 37750848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET/CT bone scan: a pictorial review.
    Sarikaya I; Elgazzar AH; Sarikaya A; Alfeeli M
    Nucl Med Commun; 2017 Oct; 38(10):810-819. PubMed ID: 28777220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of two-phase
    Seo JH; Lee SM; Yu SN; Lee JW; Lee JE
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):238-242. PubMed ID: 30665751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
    Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
    Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated classification of benign and malignant lesions in
    Perk T; Bradshaw T; Chen S; Im HJ; Cho S; Perlman S; Liu G; Jeraj R
    Phys Med Biol; 2018 Nov; 63(22):225019. PubMed ID: 30457118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical significance of incidental soft tissue uptake on whole body
    Usmani S; Gnanasegaran G; Marafi F; Esmail A; Ahmed N; Van den Wyngaert T
    Clin Radiol; 2019 Feb; 74(2):95-110. PubMed ID: 30340750
    [No Abstract]   [Full Text] [Related]  

  • 36. Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with
    Koa B; Raynor WY; Park PSU; Borja AJ; Singhal S; Kuang A; Zhang V; Werner TJ; Alavi A; Revheim ME
    PET Clin; 2022 Oct; 17(4):631-640. PubMed ID: 36229105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observer experience and accuracy of 18F-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer.
    Zacho HD; Ravn S; Ejlersen JA; Fledelius J; Dolliner P; Nygaard ST; Holdgaard PC; Lauridsen JF; Haarmark C; Hendel HW; Petersen LJ
    Nucl Med Commun; 2022 Jun; 43(6):680-686. PubMed ID: 35362691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of Benign Bone Conditions on NaF-PET.
    Rohren EM; Macapinlac HA
    Semin Nucl Med; 2017 Jul; 47(4):392-396. PubMed ID: 28583278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Assessment of Early [
    Harmon SA; Perk T; Lin C; Eickhoff J; Choyke PL; Dahut WL; Apolo AB; Humm JL; Larson SM; Morris MJ; Liu G; Jeraj R
    J Clin Oncol; 2017 Aug; 35(24):2829-2837. PubMed ID: 28654366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of
    Mogensen AW; Petersen LJ; Torp-Pedersen C; Nørgaard M; Pank MT; Zacho HD
    BMJ Open; 2022 Jun; 12(6):e058898. PubMed ID: 35705343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.